Literature DB >> 7616754

Clinical development plan: N-Acetyl-l-cysteine.

G J Kelloff1, J A Crowell, C W Boone, V E Steele, R A Lubet, P Greenwald, D S Alberts, J M Covey, L A Doody, G G Knapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7616754

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN： 0733-1959


× No keyword cloud information.
  3 in total

1.  Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model.

Authors:  Qing-Shuo Zhang; Laura Marquez-Loza; Andrea M Sheehan; Kevin Watanabe-Smith; Laura Eaton; Eric Benedetti; Angela Major; Kathryn Schubert; Matthew Deater; Eric Joseph; Markus Grompe
Journal:  Pediatr Blood Cancer       Date:  2013-09-20       Impact factor: 3.167

2.  Reduction of estrogen-induced transformation of mouse mammary epithelial cells by N-acetylcysteine.

Authors:  Divya Venugopal; Muhammad Zahid; Paula C Mailander; Jane L Meza; Eleanor G Rogan; Ercole L Cavalieri; Dhrubajyoti Chakravarti
Journal:  J Steroid Biochem Mol Biol       Date:  2007-12-07       Impact factor: 4.292

3.  The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo.

Authors:  Jaclyn Sceneay; Mira C P Liu; Anna Chen; Christina S F Wong; David D L Bowtell; Andreas Möller
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.